NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression

NUP155 interacted with NDC1 to complete the assembly of the nuclear pore complex, which promoted the development of NSCLC. Our study demonstrated that NUP155 was expected to be a potential target for the treatment of NSCLC.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2024-12-10
DOI
https://doi.org/10.3389/fphar.2024.1514367
Citations
4
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
0.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression

Zhihao Yang, Wentao Hu, Kaimin Li, Meng Li
4 citations
Frontiers in Pharmacology
RNA Research and Splicing
0.94
article

NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression

Zhihao Yang, Wentao Hu, Kaimin Li, Meng Li
article en
4 citations

Abstract

NUP155 interacted with NDC1 to complete the assembly of the nuclear pore complex, which promoted the development of NSCLC. Our study demonstrated that NUP155 was expected to be a potential target for the treatment of NSCLC.

Frontiers in PharmacologyVol. 15
Ningbo University (CN)
Good health and well-being
Openalex Percentile: Top 24%
RNA Research and Splicing
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression — Zhihao Yang, Wentao Hu, et al. · Frontiers in Pharmacology (2024) | TGRS Research Map | TGRS